Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma

Although sometimes presenting as an indolent lymphoma, mantle cell lymphoma (MCL) is an aggressive disease, hardly curable with standard chemo-immunotherapy. Current approaches have greatly improved patients’ outcomes, nevertheless the disease is still characterized by high relapse rates. Before app...

Descripción completa

Detalles Bibliográficos
Autores principales: Broccoli, Alessandro, Casadei, Beatrice, Morigi, Alice, Sottotetti, Federico, Gotti, Manuel, Spina, Michele, Volpetti, Stefano, Ferrero, Simone, Spina, Francesco, Pisani, Francesco, Merli, Michele, Visco, Carlo, Paolini, Rossella, Zilioli, Vittorio Ruggero, Baldini, Luca, Di Renzo, Nicola, Tosi, Patrizia, Cascavilla, Nicola, Molica, Stefano, Ilariucci, Fiorella, Rigolin, Gian Matteo, D'Alò, Francesco, Vanazzi, Anna, Santambrogio, Elisa, Marasca, Roberto, Mastrullo, Lucia, Castellino, Claudia, Desabbata, Giovanni, Scortechini, Ilaria, Trentin, Livio, Morello, Lucia, Argnani, Lisa, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955107/
https://www.ncbi.nlm.nih.gov/pubmed/29805746
http://dx.doi.org/10.18632/oncotarget.25215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955107/
https://www.ncbi.nlm.nih.gov/pubmed/29805746
http://dx.doi.org/10.18632/oncotarget.25215

Ejemplares similares